Vijaya Diagnostic Centre Limited has informed the Exchange about change in Management
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vijaya Diagnostic Centre Limited's Board has appointed two Additional Directors in the Non-Executive Independent category via circular resolution. Mr. Satyanaryana Murthy Chavali, a former CEO of Aurigene Discovery Technologies with deep pharmaceutical and life sciences experience, has been appointed for a 5-year term. Mr. Dipinder Singh Sekhon, a technology entrepreneur and AI specialist with over two decades of experience in medical imaging and healthcare AI, has been appointed for a 2-year term. Both appointments are effective from May 26, 2026, and are subject to shareholder approval. Neither director has any relationship with existing board members or any debarment flags.
The appointment of two highly credentialed independent directors—one with pharma/life sciences expertise and another with AI/technology background—strengthens board composition and brings relevant expertise for a diagnostic company; likely positive for governance perception.